Kenneth Lee

Kenneth Lee

Amministratore Delegato presso
Project Data Sphere LLC
78 anni
Health Technology
Commercial Services
Finance

Profilo

Mr. Kenneth B. Lee is a Venture Partner at Hatteras Venture Partners, an Executive Chairman & Chief Executive Officer at Project Data Sphere LLC and an Investment Advisor at HBM Biocapital Ltd. Mr. Lee was previously employed as a Lead Independent Director by Eyenovia, Inc., an Independent Director by Versartis, Inc., an Independent Director by BioCryst Pharmaceuticals, Inc., a Lead Independent Director by Maxygen, Inc., a Chairman by Inspire Pharmaceuticals, Inc., a Lead Independent Director by POZEN, Inc., a Lead Independent Director by CV Therapeutics, Inc., a President by A. M.
Pappas & Associates LLC, a MD-Health Sciences Corporate Finance Group by Ernst & Young Corp.
Finance LLC, a Partner & Head-International Life Sciences by Ernst & Young LLP, a Manager-National Life Sciences by Genentech, Inc., a President & Director by A M Pappas & Associates LLC, an Advisor by Affymax, Inc., an Advisor by Affymetrix, Inc., an Advisor by ALZA Corp., an Advisor by Applied Immune Sciences, Inc., an Executive Chairman & Chief Executive Officer by CEO Roundtable on Cancer, Inc., an Advisor by Chiron Corp., an Advisor by Circadian, Inc., an Advisor by Collagen Corp., a General Partner by Hatteras Biocapital LLC, an Advisor by Heartport, Inc., an Independent Director by Aralez Pharmaceuticals, Inc., and an Advisor by Systemix, Inc. He also served on the board at Aerami Therapeutics Holdings, Inc., OSI Pharmaceuticals, Inc., Abgenix, Inc., Aerami Therapeutics, Inc., AgTech Accelerator Corp., California Healthcare Institute, Clinipace, Inc., Clinverse, Inc., ibiliti, NC Life Sciences Organization and The North Carolina Biotechnology Center.
He received his undergraduate degree from Lenoir-Rhyne University and an MBA from The University of North Carolina at Chapel Hill.

Posizioni attive di Kenneth Lee

SocietàPosizioneInizio
Investitore di Private Equity 01/01/2003
Corporate Officer/Principal -
Amministratore Delegato -

Precedenti posizioni note di Kenneth Lee

SocietàPosizioneFine
BIOCRYST PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 31/12/2023
HYPERION DEFI, INC. Direttore/Membro del Consiglio 30/09/2022
OLD API WIND-DOWN LTD. Direttore/Membro del Consiglio 30/05/2019
POZEN INC. Direttore/Membro del Consiglio 05/02/2016
Direttore/Membro del Consiglio 29/08/2013
Vedi nel dettaglio l'esperienza di Kenneth Lee

Formazione di Kenneth Lee

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

80

Relazioni di 1° grado

40

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private40

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Consumer Services

Technology Services

Finance

Health Technology

Finance

Commercial Services

Hatteras Biocapital LLC

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Finance

Technology Services

  1. Mercati
  2. Insiders
  3. Kenneth Lee